First Tracks Biotherapeutics, Inc. (TRAX)
30.87
-0.52
(-1.66%)
USD |
NASDAQ |
Oct 07, 13:25
First Tracks Biotherapeutics EPS Diluted (Quarterly) : -0.943 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.943 |
| March 31, 2026 | -1.447 |
| Date | Value |
|---|---|
| June 30, 2025 | -1.199 |
| March 31, 2025 | -1.353 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Forte Biosciences, Inc. | -0.9808 |
| AnaptysBio, Inc. | 6.185 |
| Immunovant, Inc. | -0.7454 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Agenus, Inc. | -0.0146 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.37M |
| Total Expenses (Quarterly) | 33.37M |
| Enterprise Value | 947.23M |
| Earnings Yield | -16.01% |
| Normalized Earnings Yield | -16.01 |